300
Participants
Start Date
October 10, 2019
Primary Completion Date
June 14, 2024
Study Completion Date
June 14, 2024
ANAVEX2-73
Oral capsules
Central Coast Neurosciences Research, Central Coast
Hornsby (Northern Sydney Health), Hornsby
Sydney, Hornsby
KaRa MINDS, Macquarie Park
Sydney, Macquarie Park
Sydney, Sydney
University of Sydney, Sydney
Sydney, Sydney
Gold Coast, Gold Coast
Gold Coast Memory Disorders Clinic, Southport
Adelaide, Adelaide
Melbourne, Belmont
Geelong Private Medical Centre, Geelong
Delmont Private Hospital, Glen Iris
Hammond Care, Malvern
Melbourne, Malvern
Austin Health, Melbourne
Melbourne, Melbourne
Melbourne, Melbourne N.
McCusker, Nedlands
Melbourne, Delmont
Hammond Health, Malvern
Melbourne, Melbourne E.
Healthy Brain Aging Labs Uni of Calgary, Calgary
Bruyere Continuing Care, Ottawa
Kawartha Centre, Peterborough
Bay Crest Health Sciences, Toronto
Toronto Memory Program, Toronto
University of Ulm, Memory Clinic, Ulm
Bayreuth Clinic, Hohe Warte Hospital, Bayreuth
Technical University of Munich, School of Medicine, München
Central Institute of Mental Health, Mannheim
Goettingen University Medicine, Clinic for Psychiatry and Psychotherapy, Göttingen
University Hospital, Bonn, Bonn
Clinic for Psychiatry and Psychotherapy, Mainz
Charite University Medicine, Berlin
Brain Research Center, 's-Hertogenbosch
Brain Research Center, Amsterdam
Brain Research Center, Zwolle
MAC Clinical Research, Teesside
Glasgow Memory Clinic, Glasgow
Cognition Health, Guildford
MAC Clinical Research, Barnsley
MAC Clinical Research, Blackpool
MAC Clinical Research, Cannock
MAC Clinical Research, Leeds
MAC Clinical Research, Liverpool
Cognition Health, London
Imperial College, London
MAC Clinical Research, Manchester
Cognition Health, Plymouth
Lead Sponsor
Anavex Australia Pty Ltd.
INDUSTRY
Anavex Germany GmbH
INDUSTRY
Anavex Life Sciences Corp.
INDUSTRY